DUBLIN--(BUSINESS WIRE)--The "Diabetes Care Devices Market by Product - Global Opportunity Analysis and Industry Forecasts, 2017-2023" report has been added to ResearchAndMarkets.com's offering.
The global diabetes care devices market was valued at $6,867 million in 2016, and is growing at a CAGR of 5.8% from 2017 to 2023 to reach $10,208 million by 2023.
The major factor that contributes to the growth of the diabetes care devices market include the increase in incidence rate of diabetes caused by rapid urbanization and sedentary lifestyle. Moreover, technological advancements in the field of diabetes devices, rise in obese population, consumption of junk food, and surge in need for faster and safer diagnosis and treatment of diabetes further boosts the market growth.
However, blood glucose monitoring devices do not measure the exact level of glucose in blood and give a range in which the blood glucose level of a patient may lie. In addition, adverse effects associated with some of the diabetes care devices also hinder the market growth.
Rise in awareness about diabetes monitoring devices, and untapped market opportunities in the developing regions are expected to provide numerous opportunities for the market growth.
Based on type, the market is bifurcated into blood glucose monitoring devices and insulin delivery devices.
- Blood glucose monitoring devices are categorized into testing strips, self-monitoring blood glucose meters, lancets, and continuous glucose monitoring devices.
- Insulin delivery devices segment is further divided into insulin syringes, insulin pens, insulin pumps, and insulin jet injectors.
By geography, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, Italy, UK, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Key Players Profiled
- Abbott Laboratories
- ACON Laboratories, Inc.
- Ascensia Diabetes Care Holdings AG (formerly diabetes case business of Bayer AG)
- Becton, Dickinson and Company
- Dexcom, Inc.
- F. Hoffmann-La Roche Ltd
- Johnson & Johnson
- Medtronic plc
- Novo Nordisk A/S
- Terumo Corporation
Other Players in the Value Chain
- Arkray, Inc.
- Echo Therapeutics, Inc.
- Glysens Incorporated
- Insulet Corporation
- Ypsomed AG
Key Topics Covered
Chapter 1 Introduction
Chapter 2 Executive Summary
Chapter 3 Market Overview
Chapter 4 Global Diabetes Care Devices Market, by Product
Chapter 5 Diabetes Care Devices Market, by Region
Chapter 6 Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/xd5z28/global_10_2?w=4